PeroxiBiokey

PeroxiBiokey is a biotechnology company focused on developing novel therapeutics that target peroxisome dysfunction to treat rare genetic diseases and age-related conditions. The company's proprietary platform identifies small molecules capable of restoring or enhancing peroxisomal function, which is critical for lipid metabolism and cellular redox balance. Their lead programs target Zellweger spectrum disorder and X-linked adrenoleukodystrophy, with additional research into neurodegenerative and metabolic diseases. By addressing the underlying organelle dysfunction, PeroxiBiokey aims to provide first-in-class treatments for disorders with high unmet medical needs.